Autism's genetic chaos may follow just two molecular playbooks

Autism spectrum disorder (ASD) is linked to more than 1,200 risk genes — a staggering diversity that has long made it hard to find common biological ground. Now, a team from the Institute for Basic Science (IBS) in South Korea has found that, despite this genetic variety, the brain's molecular response to autism-risk mutations may converge into just two opposing patterns.

Analyzing RNA-sequencing data from 17 genetically engineered mouse lines — covering over 1,000 brain transcriptomes — researchers identified two broad molecular groups. In Group 1, synaptic communication genes were underexpressed while chromatin regulation genes were overexpressed. Group 2 showed the exact opposite. Crucially, the grouping wasn't fixed: the same mutation could land a male mouse in one group and a female in another, and patterns shifted with developmental stage and brain region.

The two groups also responded differently to fluoxetine and lithium, two drugs previously studied in autism mouse models. Group 1 showed more consistent gene-expression shifts toward control patterns; Group 2 was more variable. Preliminary human data from 40 autistic individuals hinted at similar subgroupings, though immune-related differences were more prominent in humans.

Key Takeaways:

• Two opposing molecular brain states were identified across genetically diverse ASD mouse models
• Sex, developmental stage, and brain region all influenced which group a mouse fell into
• Drug responses to fluoxetine and lithium differed between the two groups, suggesting molecular subtyping could guide future preclinical research
• Human data showed analogous subgroupings, but patterns were not identical to those found in mice

Why it matters: This framework could help researchers move beyond gene-by-gene analysis toward shared biological mechanisms — a critical step for developing therapies that work across ASD's vast genetic landscape.